An update on coronary heart disease in women

International Journal of Fertility and Women's Medicine

Volumn 43, Issue 2, 1998, Pages 84-90

  Wenger, Nanette K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary heart disease; Coronary prevention; Coronary risk factors; Gender differences; Myocardial infarction; Myocardial revascularization; Women

Indexed keywords

ADULT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY RISK; FEMALE; GRAFT PATENCY; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART PERFORMANCE; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SEX DIFFERENCE; THORAX PAIN;

EID: 0031776847     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Wenger NK: Coronary heart disease in women: Evolving knowledge is dramatically changing clinical care, in Julian DG, Wenger NK (eds): Women and Heart Disease, London, Martin Dunitz, pp 21-38, 1997.
2. Gillum RF, Mussolino ME, Madans JH: Coronary heart disease incidence and survival in AfricanAmerican women and men. The NHANES I Epidemiologic Follow-up Study. Ann Intern Med 127:111-118, 1997.
3. Lerner DJ, Kannel WB: Patterns of coronary heart disease morbidity and mortality in the sexes: A 26year follow-up of the Framingham population. Am Heart J 111:383-390, 1986.
4. Kennedy JW, Killip T, Fisher LD, et al: The clinical spectrum of coronary artery disease and its surgical and medical management, 1974-1979. The Coronary Artery Surgery Study. Circulation 66 (suppl III):III-16-III-23, 1982.
5. Wenger NK (guest ed): Symposium: Gender Differences in Cardiac Imaging. Am J Card Imaging 10:42-88, 1996.
6. Lehmann JB, Wehner PS, Lehmann CU, et al: Gender bias in the evaluation of chest pain in the emergency department. Am J Cardiol 77:641-644, 1996.
7. Lauer MS, Pashkow FJ, Snader CE, et al: Gender and referral for coronary angiography after treadmill thallium testing. Am J Cardiol 78:278-283, 1996.
8. Weintraub WS, Kosinski AS, Wenger NK: Is there a bias against performing coronary revascularization in women? Am J Cardiol 78:1154-1160, 1996.
9. Kannel WB, Abbott RD: Incidence and prognosis of myocardial infarction in women: The Framingham Study, in Eaker ED, Packard B, Wenger NK, et al (eds): Coronary Heart Disease in Women. New York, Haymarket Doyma, pp 208-214, 1987.
10. Kudenchuck PJ, Maynard C, Martin JS, et al, for the MITI Project Investigators: Comparison of presentation, treatment, and outcome of acute myocardial infarction in men versus women (The Myocardial Infarction Triage and Intervention Registry). Am J Cardiol 78:9-14, 1996.
11. Jenkins JS, Flaker GC, Nolte B, et al: Causes of higher in-hospital mortality in women than in men after acute myocardial infarction. Am J Cardiol 73:319-322, 1994.
12. Lee KL, Woodlief LH, Topol EJ, et al: Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Circulation 91:1659-1668, 1995.
13. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI): Long-term effects of intravenous thrombolysis in acute myocardial infarction. Final report of the GISSI study. Lancet 2:871-874, 1987.
14. Stone GW, Grines CL, Browne KF, et al: Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction. Am J Caidiol 75:987-992, 1995.
15. McLaughlin TJ, Soumerai SB, Willison DJ, et al: Adherence to national guidelines for drug treatment of suspected acute myocardial infarction. Evidence for undertreatment in women and the elderly. Arch Intern Med 156:799-805, 1996.
16. Maynard C, Weaver WD: Treatment of women with acute MI: new findings from the MITI Registry. J Myocard Ischemia 4:27-37, 1992.
17. Loop FD, Golding LR, MacMillan JP, et al: Coronary artery surgery in women compared with men. Analyses of risks and long-term results. J Am Coll Cardiol 1:383-390, 1983.
18. Kelsey SF, James M, Holubkov AL, et al, and the Investigators from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry: Results of percutaneous transluminal coronary angioplasty in women: 1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry. Circulation 87:720-727, 1993.
19. Bell MR, Grill DE, Garratt KN, et al: Long-term outcome of women compared with men after successful coronary angioplasty. Circulation 91:2876-2881, 1995.
20. Welty FK, Mittleman MA, Healy RW, et al: Similar results of percutaneous transluminal coronary angioplasty for women and men with postmyocardial infarction ischemia. J Am Coll Cardiol 23:35-39, 1994.
21. Weintraub WS, Wenger NK, Delafontaine P, et al: PTCA in women compared to men: Is there a difference in risk? Circulation 86 (suppl I):I-253, 1992 (Abst).
22. Eaker ED, Chesebro JH, Sacks FM, et al: Cardiovascular disease in women. Circulation 88 (part 1 ):1999-2009, 1993.
23. National Center for Health Statistics: Health: United States, 1990, U.S. Public Health Service, Hyattsville, MD: Centers for Disease Control, 1991.
24. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383-1389, 1994.
25. Sacks FM, Pfeffer MA, Moyé LA, et al, for the Cholesterol and Recurrent Events Trial Investigators: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335:1001-1009, 1996.
26. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265:3255-3264, 1991.
27. Barrett-Connor EL, Cohn BA, Wingard DL, et al: Why is diabetes mellitus a stronger risk factor for fatal ischemie heart disease in women than in men? The Rancho Bernardo Study. JAMA 265:627-631, 1991.
28. Manson JE, Colditz GA, Stampfer MJ, et al: A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 151:1141-1147, 1991.
29. Manson JE, Rimm EB, Stampfer MJ, et al: Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338:774-778, 1991.
30. Willett WC, Green A, Stampfer MJ, et al: Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 317:1303-1309, 1987.
31. Hansen EF, Andersen LT, Von Eyben FE: Cigarette smoking and age at first acute myocardial infarction and influence of gender and extent of smoking. Am J Cardiol 71:1439-1442, 1993.
32. Kawachi I, Colditz GA, Stampfer MJ, et al: Smoking cessation in relation to total mortality rates in women. A prospective cohort study. Ann Intern Med 119:992-1000, 1993.
33. Hartz A, Grubb B, Wild R, et al: The association of waist hip ratio and angiographically determined coronary artery disease. Int J Obesity 14:657-665, 1990.
34. Anda RF, Waller NM, Wooten KG, et al: Behavioral risk factor surveillance, 1988. MMWR 39 (SS2):1-21, 1990.
35. Kushi LH, Fee RM, Folsom AR, et al: Physical activity and mortality in postmenopausal women. JAMA 277:1287-1292, 1997.
36. Wenger NK: Postmenopausal hormone therapy: Is it useful for coronary prevention: (Plausible mechanisms and available data). Cardiol Clin, February 1998.
37. The Writing Group for the PEPI Trial: Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 273:199-208, 1995.